220 related articles for article (PubMed ID: 26209438)
1. Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.
Hong CQ; Zhang F; You YJ; Qiu WL; Giuliano AE; Cui XJ; Zhang GJ; Cui YK
BMC Cancer; 2015 Jul; 15():548. PubMed ID: 26209438
[TBL] [Abstract][Full Text] [Related]
2. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F
Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract][Full Text] [Related]
4. CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells.
Yu JH; Zhong XY; Zhang WG; Wang ZD; Dong Q; Tai S; Li H; Cui YF
Oncol Rep; 2012 Apr; 27(4):1266-76. PubMed ID: 22209942
[TBL] [Abstract][Full Text] [Related]
5. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
6. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
8. Downregulated CDK10 expression in gastric cancer: Association with tumor progression and poor prognosis.
You Y; Bai F; Ye Z; Zhang N; Yao L; Tang Y; Li X
Mol Med Rep; 2018 May; 17(5):6812-6818. PubMed ID: 29512714
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
10. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
Cheang TY; Zhou HY; Chen W; Zhang B; Liu L; Yang J; Wang S; Li H
J Transl Med; 2016 Feb; 14():54. PubMed ID: 26883017
[TBL] [Abstract][Full Text] [Related]
11. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.
You Y; Li H; Qin X; Ran Y; Wang F
Cell Oncol (Dordr); 2016 Feb; 39(1):89-95. PubMed ID: 26631111
[TBL] [Abstract][Full Text] [Related]
13. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
[TBL] [Abstract][Full Text] [Related]
14. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
16. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.
Huang X; Li X; Xie X; Ye F; Chen B; Song C; Tang H; Xie X
Breast; 2016 Dec; 30():39-46. PubMed ID: 27598996
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer.
Wan G; Tian L; Yu Y; Li F; Wang X; Li C; Deng S; Yu X; Cai X; Zuo Z; Cao F
Biochem Biophys Res Commun; 2017 Sep; 491(1):104-111. PubMed ID: 28709865
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
20. HBXIP expression predicts patient prognosis in breast cancer.
Cheng D; Liang B; Li Y
Med Oncol; 2014 Oct; 31(10):210. PubMed ID: 25178941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
